TATEO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 253
Continente sconosciuto - Info sul continente non disponibili 194
AS - Asia 141
EU - Europa 123
SA - Sud America 1
Totale 712
Nazione #
US - Stati Uniti d'America 230
BD - Bangladesh 97
IT - Italia 81
SE - Svezia 25
CN - Cina 18
SG - Singapore 14
CA - Canada 13
HK - Hong Kong 6
DE - Germania 4
IE - Irlanda 4
MX - Messico 3
SA - Arabia Saudita 3
FI - Finlandia 2
ID - Indonesia 2
JM - Giamaica 2
NI - Nicaragua 2
NL - Olanda 2
BE - Belgio 1
BR - Brasile 1
CR - Costa Rica 1
CU - Cuba 1
FR - Francia 1
GB - Regno Unito 1
HN - Honduras 1
LT - Lituania 1
PH - Filippine 1
PT - Portogallo 1
Totale 518
Città #
Ashburn 39
Phoenix 28
Dallas 18
Santa Clara 17
Rome 15
San Jose 15
Beijing 12
Los Angeles 10
New York 10
Hong Kong 6
Singapore 6
Bologna 5
Buffalo 5
Naples 5
Jinhua 4
North Kansas City 4
San Francisco 4
Turin 4
Boardman 3
Florence 3
Houston 3
Medina 3
Mexico City 3
Milan 3
The Dalles 3
Atlanta 2
Bremen 2
Calgary 2
Columbus 2
Dublin 2
Jacksonville 2
Las Vegas 2
Managua 2
Milwaukee 2
Munich 2
Portsmouth 2
Queens 2
Toronto 2
Alajuela 1
Alexandria 1
Aliso Viejo 1
Almont 1
Ames 1
Angri 1
Ascea 1
Balikpapan 1
Bari 1
Berwyn 1
Bethlehem 1
Blacklick 1
Bluffton 1
Bowie 1
Brentwood 1
Briatico 1
Brussels 1
Catania 1
Cebu City 1
Charlemont 1
Chicago 1
Civitella Casanova 1
Concord 1
Coquitlam 1
Danlí 1
Denpasar 1
Denver 1
Elmhurst 1
Espoo 1
Eugene 1
Fairfax 1
Gastonia 1
Grande Prairie 1
Hagerstown 1
Havana 1
Helsinki 1
Highland Park 1
Holland 1
Hyattsville 1
Indpls 1
Kapolei 1
Kaunas 1
Kingston 1
Laval 1
Lebanon 1
Lucca 1
Manassas 1
Mantua 1
Memphis 1
Mesa 1
Mississauga 1
Mobile 1
Modena 1
Moncton 1
Mount Shasta 1
Nanticoke 1
New Orleans 1
North York 1
Orem 1
Orrville 1
Padua 1
Pagani 1
Totale 316
Nome #
Anastomotic Leakage after Colorectal Surgery in Ovarian Cancer: Drainage, Stoma Utility and Risk Factors 73
Sentinel lymph node mapping in endometrial cancer: new insights into an essential tool 15
Diagnosi e terapia del carcinoma ovarico 9
Adenomyosis 8
PERIOPERATIVE AND ONCOLOGICAL OUTCOMES IN LOW RISK ENDOMETRIAL CANCER WITH SENTINEL LYMPH NODE DISSECTION 8
Ultrasound patterns compared to histopathological findings in ovarian granulosa cell tumor 8
Comparison of robotic single-site (RSS) and robotic multiport (RM) total hysterectomy (TH) plus sentinel lymph node (SLN) mapping in low risk endometrial cancer (EC): quality of life (QoL) and surgical outcomes analysis 6
ICON1. EORTC ACTION trials investigators. International Collaborative Ovarian Neoplasm trial 1 and Adiuvant Chemotherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma 6
Studio immunocitochimico e citofluorimetrico sulla proliferazione cellulare e sulla ploidia nella placenta umana. 6
TOTAL LAPAROSCOPIC HISTERECTOMY WITH UTERINE MANIPULATION IN THE MANAGEMENT OF ENDOMETRIAL CANCER 6
Comparison between two different methods of abdominal incision techniques in hysterectomy for uterine cancer 6
A COMPARISON OF THE ANTIEMETIC EFFICACY AND SAFETY OF INTRAMUSCULAR AND INTRAVENOUS FORMULATIONS OF GRANISETRON IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY 6
Childbirth Care among SARS-CoV-2 Positive Women in Italy 6
Robotic single site sentinel lymph node fluorescence detection 6
Low proliferative activity: a possible prognostic factor for survival in advanced ovarian cancer. 5
Valutazione di alcuni parametri nel timing del parto nella IUGR. 5
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer 5
Recurrent Urinary Tract Infection in Young Woman 5
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery. 5
CA125 and CA 15 3 in endometrial adenocarcinoma. 5
A phase III trial of consolidation versus NIHIL (NIL) for advance epithelial ovarian cancer. 5
Are the results obtained in randomized clinical trials on antiemetics sufficiently reproducible in clinical practice? 5
Clear cell ovarian cancer in stage I disease high risk of thromboembolic events at diagnosis 5
Pattern of failures of patients with recurrent epithelial ovarian cancer. 5
Primary retroperitoneal mucinous cystoadenocarcinomas express markers of gastric, intestinal and pancreatobiliary epithelial cells. 5
A randomized study in recurrent ovarian cancer comparing the efficacy of single agent versus combination chemotherapy, according to time to relapse 5
Feasibility of sentinel lymph node fluorescence detection during robotic laparoendoscopic single-site surgery in early endometrial cancer: a prospective case series 5
Wound complications after midline laparotomy in endometrial cancer patients. A multicentric trial 5
CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES 5
Ploidia e attività proliferativa dei tumori uterini: studio mediante bromodesossiuridina e citofluorimetria a flusso 5
Ondansetron vs metoclopramide both combined with desamethasone in the prevention of cisplatin-induced emesis 4
Complications of lymphadenectomy in endometrial cancer. Results of a prospective randomized multicentric clinical trial 4
CA125 and CA15 3 serum levels in endometrial carcinoma 4
Apple consumption is related to better sexual quality of life in young women 4
Previous treated cervical cancer: sentinel lymph node detection 4
La colposospensione al legamento sacrospinoso nel trattamento e nella profilassi del prolasso utero-vaginale. 4
Childbirth Care among SARS-CoV-2 Positive Women in Italy 4
Role on servival of pelvic/aortic Iymph node status in advanced ovarian cancer. 4
Preoperative abdominopelvic computed tomography and cytoreduction in advanced epithelial ovarian cancer 4
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 4
A multicentre collaborative study on the use of cold scalpel and electrocautery for midline abdominal incision 4
SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study 4
A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer 4
Coronavirus and birth in Italy: results of a national population-based cohort study 4
Lymph node metastases in endometrial carcinoma. 4
Optimal dose of intravenous dexamethasone in the prevention of cisplatin induced acute emesis: a double- blind randomized study. 4
DNA-PLOIDY AND PROLIFERATIVE ACTIVITY IN UTERINE-TUMORS - AN IN-VIVO STUDY USING BROMODEOXYURIDINE AND FLOW-CYTOMETRY 4
Increasing incidence of cerebral metastases in epithelial ovarian cancer. 4
Feasibility and complications of systematic lymphadenectomy in endometrial cancer. Preliminary results of a prospective randimized multicentric clinical trial 4
p 53 mutation in primary cervical adenocarcinoma: pathologic and molecular correlations. 4
Radioguided sentinel lymph node detection in vulvar cancer 4
Ondansetron vs metoclopramide both combined with desamethasone in the prevention of cisplatin-induced delayed emesis 4
"Less is More, is R-LESS More?"-The Use of Robotic Laparoendoscopic Single-Site Surgery in Gynaecology: A Scoping Review 4
A multicenter randomized trial comparing two different doses of Taxol (T) plus a fixed doses of Carboplatin (C) in advanced ovarian cancer. 4
Weekly Paclitaxel in late relapse of epithelial ovarian cancer after development of platinum resistant disease. 4
Monitoraggio clinico-strumentale del carcinoma ovarico dopo prima linea chemioterapica 4
The clinical value of computed tomography and lymphography in detecting lymph node metastases from epithelial ovarian cancer. 4
Staging of borderline ovarian tumor: peritoneal directed and random biopsies. 4
Uterine volume can be considered as parameter of gonadal function in Turner Syndrome 4
Echec terapeutique dans le cancer du col de la jeune femme 4
Second uterine malignancy after radiation or chemoradiation treatment for advanced cervical cancer. 4
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer 4
Venous thromboembolism incidence in ovarian cancer patients. 4
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 4
Carcinoma della cervice uterina: chemioterapia neoadiuvante con ifosfamide e platino settimanale. 4
Il ruolo della tomografia computerizzata nel follow up delle neoplasie ginecologiche. 4
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY 4
CT findings of ovarian fibrothecomas 4
Localization of lipoperoxidation adducts in normal and pathological human tissues 4
: Sentinel lymphnodes radioguided localization in vulvar cancer. 4
Chemioterapia di induzione nel carcinoma della cervice uterina stadio IB/IIA bulky e IIB. 4
Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients? 4
Phase II study withTopotecan (TPT) as sequential chemotherapy 114 advanced ovarian cancer (AEOC) patients (P15) with small residual disease (SRD) after Taxol-Carboplatin (TC) as first-line Chemotherapy 4
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9) 4
Successful pregnancy and vaginal birth in a patient with Fanconi-Bickel Syndrome – case report and literature review 3
MISSED DIAGNOSES REVEALED AT NECROPSY IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES 3
PRIMARY MUCINOUS CYSTOADENOCARCINOMA OF THE RETROPERITONEUM - 2 CASES 3
Chromosome instability in cultured lymphocytes of patients with ovarian or uterine cancer 3
Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: A randomized trial 3
Lipid peroxidation and cell proliferation in human trophoblast cells as revealed by combined immunocytochemistry to 4-hydroxynoneal and proliferating cell nuclear antigen. 3
Salvage randomized trial in platinum-sensitive ovarian carcinoma (OC) 3
Progenitor cell mobilization after taxane+granulocyte colony stimulating factor in breast and gynecological cancer. 3
Analisi delle complicanze chirurgiche in pazienti sottoposte ad intervento per carcinoma endometriale. Studio Collaborativo 3
Immunohistochemical detection of reactive aldehydes: a morphological approach for the detection of free radical activity in tissues 3
Ondansetron vs metoclopramide both combined with dexamethasone in the prevention of cisplatin induced delayed emesis . 3
Persistence of efficacy of two antiemetic regimens and prognostic factors in cisplatin-treated patients. 3
CT imaging in pelvic inflammatory disease. 3
Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial 3
Identification of 4 –hydroxynonenal-immunoreactivity in human placenta 3
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 3
Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis 3
Neoadjuvant chemotherapy (NACT) and radical surgery (RS) Vs exclusive radiotherapy (RT) in locally advanced squamous cell cervical cancer (LASCCC). Results from the Italian multicenter randomized study 3
OCCURRENCE AND DISTRIBUTION OF MATRIX METALLOPROTEINASE-2-IMMUNOREACTIVITY IN HUMAN EMBRYONIC-TISSUES 3
Mobilization and cell cycle analysis of CD34(+) circulating progenitor cells after topotecan and epirubicin +/- G-CSF in advanced ovarian cancer patients 3
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial 3
Coincidental endometrial and clear cell renal carcinoma. Two case reports and literature review 3
Prognostic value of positron emission tomography (PET ) in patients with methastatic or locally advanced cervical cancer : A monoistitutional experience 3
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 3
Presence of organophosphate and organochlorine pesticides in the milk of women 3
TUMOR-ANTIGENS CA125 AND CA15-3 AS MARKERS OF ENDOMETRIAL ADENOCARCINOMA 3
Totale 503
Categoria #
all - tutte 19.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202410 0 0 0 0 0 0 0 2 2 1 2 3
2024/202523 1 1 1 4 3 0 0 0 5 5 3 0
2025/2026415 4 5 8 1 1 1 4 2 7 2 228 152
2026/2027264 159 105 0 0 0 0 0 0 0 0 0 0
Totale 712